2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Body Dysmorphic Disorders: new trials by email Literature Review of Body Dysmorphic Disorders trials Research Report on Body Dysmorphic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder Psilocybin - Body Dysmorphic Disorders | Phase 2 | Completed | New York State Psychiatric Institute | 12 | 2021-02-26 | 2023-03-13 |
| Oxytocin Administration in BDD and OCD Oxytocin, Placebo - Body Dysmorphic Disorder, Obsessive-compulsive Disorder | Phase 2 | Completed | Massachusetts General Hospital | 41 | 2014-12-01 | 2018-11-23 |
Obsessive-Compulsive Disorder (1)
Mental Disorders (2) · Somatoform Disorders (2) · Anxiety Disorders (1)
Oxytocin (1) · Psilocybin (1)
Massachusetts General Hospital (1) · New York State Psychiatric Institute (1)
United States (2)
Angela Fang, Ph.D. (1) · Franklin Schneier, MD (1)